Form 8-K - Current report:
SEC Accession No. 0001493152-24-050223
Filing Date
2024-12-16
Accepted
2024-12-16 16:20:40
Documents
15
Period of Report
2024-12-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43724
2 ex99-1.htm EX-99.1 78733
3 ex99-1_001.jpg GRAPHIC 21269
  Complete submission text file 0001493152-24-050223.txt   328735

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pure-20241216.xsd EX-101.SCH 3012
5 XBRL LABEL FILE pure-20241216_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pure-20241216_pre.xml EX-101.PRE 24163
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3279
Mailing Address 771 JAMACHA ROAD #512 EL CAJON CA 92019
Business Address 771 JAMACHA ROAD #512 EL CAJON CA 92019 619-596-8600
PURE BIOSCIENCE, INC. (Filer) CIK: 0001006028 (see all company filings)

EIN.: 330530289 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-14468 | Film No.: 241552113
SIC: 2890 Miscellaneous Chemical Products
(CF Office: 08 Industrial Applications and Services)